55.07
price up icon0.07%   0.04
after-market アフターアワーズ: 54.99 -0.08 -0.15%
loading
前日終値:
$55.03
開ける:
$55.44
24時間の取引高:
386.71K
Relative Volume:
0.76
時価総額:
$3.50B
収益:
-
当期純損益:
$-145.21M
株価収益率:
-23.94
EPS:
-2.3
ネットキャッシュフロー:
$-140.12M
1週間 パフォーマンス:
+3.73%
1か月 パフォーマンス:
+16.26%
6か月 パフォーマンス:
+20.50%
1年 パフォーマンス:
+22.62%
1日の値動き範囲:
Value
$54.36
$55.72
1週間の範囲:
Value
$52.65
$57.45
52週間の値動き範囲:
Value
$31.42
$58.26

Moonlake Immunotherapeutics Stock (MLTX) Company Profile

Name
名前
Moonlake Immunotherapeutics
Name
セクター
Healthcare (1164)
Name
電話
41 41 510 8022
Name
住所
DORFSTRASSE 29, ZUG
Name
職員
100
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
MLTX's Discussions on Twitter

MLTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MLTX
Moonlake Immunotherapeutics
55.07 3.49B 0 -145.21M -140.12M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-19 アップグレード Wolfe Research Peer Perform → Outperform
2025-03-18 開始されました RBC Capital Mkts Outperform
2025-01-17 アップグレード Goldman Neutral → Buy
2024-11-05 再開されました Wedbush Outperform
2024-08-26 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 開始されました Oppenheimer Outperform
2024-04-02 開始されました Goldman Neutral
2024-02-15 開始されました Wolfe Research Outperform
2023-12-08 開始されました Citigroup Buy
2023-11-02 開始されました Stifel Buy
2023-09-14 ダウングレード Bryan Garnier Buy → Neutral
2023-08-31 開始されました Needham Buy
2023-06-15 開始されました Barclays Equal Weight
2023-05-01 開始されました Guggenheim Buy
2023-03-22 開始されました Wedbush Outperform
2023-03-09 開始されました BTIG Research Buy
2023-02-14 開始されました Cantor Fitzgerald Overweight
2023-02-02 開始されました Bryan Garnier Buy
2022-11-11 開始されました Jefferies Buy
2022-08-25 開始されました SVB Leerink Outperform
2022-07-21 開始されました H.C. Wainwright Buy
2022-07-07 開始されました Cowen Outperform
すべてを表示

Moonlake Immunotherapeutics (MLTX) 最新ニュース

pulisher
05:20 AM

How does MoonLake Immunotherapeutics generate profit in a changing economyFree Stock Market Trend Analysis - jammulinksnews.com

05:20 AM
pulisher
03:57 AM

Does MoonLake Immunotherapeutics stock perform well during market downturnsStrong return on assets - jammulinksnews.com

03:57 AM
pulisher
02:42 AM

How strong is MoonLake Immunotherapeutics company’s balance sheetCapitalize on emerging market sectors - jammulinksnews.com

02:42 AM
pulisher
02:27 AM

How does MoonLake Immunotherapeutics compare to its industry peersInvest smarter with advanced market data - jammulinksnews.com

02:27 AM
pulisher
02:08 AM

Is MoonLake Immunotherapeutics stock overvalued or undervaluedDynamic portfolio growth - jammulinksnews.com

02:08 AM
pulisher
01:30 AM

What catalysts could drive MoonLake Immunotherapeutics stock higher in 2025Dynamic capital growth - jammulinksnews.com

01:30 AM
pulisher
11:48 AM

What are MoonLake Immunotherapeutics company’s key revenue driversBuild a diversified portfolio for stability - jammulinksnews.com

11:48 AM
pulisher
Jul 26, 2025

Does MoonLake Immunotherapeutics (NASDAQ:MLTX) Have A Healthy Balance Sheet? - 富途牛牛

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about MoonLake Immunotherapeutics stockMarket-leading profit generation - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

MoonLake Immunotherapeutics Stock Analysis and ForecastUnbelievable profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

Is MoonLake Immunotherapeutics a good long term investmentBreakthrough stock performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Podcast: Inside MoonLake’s Fast-Track Vision And $500m Deal - insights.citeline.com

Jul 23, 2025
pulisher
Jul 23, 2025

MoonLake Immunotherapeutics: Promising Phase 3 Trials and Market Potential for Sonelokimab - TipRanks

Jul 23, 2025
pulisher
Jul 22, 2025

What drives MoonLake Immunotherapeutics stock priceExplosive capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

(MLTX) Trading Advice - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 17, 2025

MoonLake Immunotherap Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily

Jul 17, 2025
pulisher
Jul 15, 2025

What makes MoonLake Immunotherapeutics stock price move sharplyFree Investment Risk Control - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why MoonLake Immunotherapeutics stock attracts strong analyst attentionFree Stock Market Insider Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How MoonLake Immunotherapeutics stock performs during market volatilityQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

MoonLake Immunotherap Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

Jul 15, 2025
pulisher
Jul 10, 2025

Merck made $3B+ offer for MoonLake earlier this yearreport - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

MoonLake Immunotherap Getting Closer To Key Technical Benchmark - Investor's Business Daily

Jul 10, 2025
pulisher
Jul 07, 2025

MoonLake Immunotherapeutics Director Makes a Major Stock Move! - TipRanks

Jul 07, 2025
pulisher
Jun 28, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Challenges - geneonline.com

Jun 28, 2025
pulisher
Jun 19, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Sector Challenges - geneonline.com

Jun 19, 2025
pulisher
Jun 16, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Developments - geneonline.com

Jun 16, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (MLTX) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 15, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments - geneonline.com

Jun 15, 2025

Moonlake Immunotherapeutics (MLTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):